IP Library Granted Patent US 9,845,457
Granted Patent B2
US 9,845,457 · App. 14/981,533 · Granted Dec 19, 2017

Maintenance of genomic stability in cultured stem cells

Inventors: Eduardo Marbán (Beverly Hills, CA); Tao-Sheng Li (Nanchang, CN)
Assignee: Cedars-Sinai Medical Center
C12N5/0662C12N5/0657C12N2500/02C12N2500/38C12N2501/998
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,845,457
App. No.
14/981,533
Granted
Dec 19, 2017
Kind
B2
Abstract

The present application relates to methods and compositions for the generation of therapeutic cells having reduced incidence of karyotypic abnormalities. In several embodiments cardiac stem cells are cultured in an antioxidant-supplemented media that reduces levels of reactive oxygen species, but does not down regulate DNA repair mechanisms. In several embodiments, physiological oxygen concentrations are used during culture in order to increase the proliferation of stem cells, decrease the senescence of the cells, decrease genomic instability, and/or augment the functionality of such cells for cellular therapies.

Claims (10)

1. A method for reducing the incidence of karyotypic abnormalities in cardiac stem cells for use in the repair or regeneration of cardiac tissue, the method comprising:

culturing cardiac stem cells in a culture media supplemented with an antioxidant composition,

wherein said antioxidant composition comprises glutathione present in a concentration ranging from 5 to 20 μM, vitamin C present in a concentration ranging from 5 to 20 μM, and vitamin E present in a concentration ranging from 5 to 20 μM.

2. The method of claim 1 , wherein said cardiac stem cells are cardiosphere-derived cells (CDCs).

3. The method according to claim 1 , wherein said glutathione is present in a concentration of 10 μM.

4. The method of claim 1 , wherein said antioxidant further comprises one or more of thiols and polyphenols.

5. The method of claim 1 , wherein said antioxidant further comprises vitamin A.

6. The method of claim 1 , wherein at least one of said vitamin C and said vitamin E is present in a concentration of 10 μM.

7. The method of claim 1 , wherein said culturing is for at least about 24 hours.

8. The method of claim 1 , wherein said at least one peptide antioxidant is glutathione, wherein said glutathione is present in a concentration ranging from 10 μM, wherein said at least one non-peptide antioxidant comprises vitamin C and vitamin E, and wherein each of said vitamin C and vitamin E is present in a concentration ranging from about 10 μM.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2019
From: MARBAN, EDUARDO; LI, TAO-SHENG
To: CEDARS-SINAI MEDICAL CENTER
Reel/Frame 051253/0407 →
CONFIRMATORY LICENSE Recorded Dec 11, 2019
From: CEDARS-SINAI MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 051258/0718 →
Continuity (3)
Continuation In Part 13096931 · Apr 28, 2011
Provisional Application 61330251 · Apr 30, 2010
Related Publication 20160108365A1 · Apr 21, 2016